Atlas Trials

Dual Integrin αvβ3 and GRPR Targeting PET Imaging in Breast Cancer Patients

Clinical trial NCT02749019 · UNKNOWN

Trial details

NCT number
NCT02749019
Sponsor
Peking Union Medical College Hospital
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Breast Cancer
Start date
2015-07-01
Primary completion
2018-07-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.